Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial

Related articles

1. Comparative Analysis of Maintenance Treatments in Patients with Newly Diagnosed Advanced Ovarian Cancer After First-Line Platinum-Based Regimens

   This article has 8 authors:

   1. Lorenzo Gasperoni
   2. Luca Cancanelli
   3. Andrea Ossato
   4. Luna Del Bono
   5. Stefano Vecchia
   6. Caterina Fontanella
   7. Vera Damuzzo
   8. Andrea Messori

2. First real-world experience with 1L pembrolizumab and chemotherapy treatment for advanced triple-negative breast cancer in Poland: safety analysis and first survival outcomes from a multicenter cohort

   This article has 22 authors:

   1. Małgorzata Pieniążek
   2. Aleksandra Konieczna
   3. Katarzyna Świderska
   4. Iwona Danielewicz
   5. Roman Dubiański
   6. Karolina Winsko-Szczęsnowicz
   7. Agnieszka Roman
   8. Justyna Żubrowska
   9. Tomasz Ciszewski
   10. Natalia Cichowska-Cwalińska
   11. Wioleta Łabul
   12. Anna Górniak
   13. Joanna Pleskacz
   14. Ewa Wójcik
   15. Małgorzata Meluch
   16. Jakub Wronowicz
   17. Bogumiła Czartoryska-Arłukowicz
   18. Michał Jarząb
   19. Marek Jasiówka
   20. Aleksandra Łacko
   21. Renata Pacholczak-Madej
   22. Mirosława Püsküllüoğlu

3. Efficacy of concurrent intensity modulated chemoradiotherapy combined with induction chemotherapy or adjuvant chemotherapy in the treatment of locally advanced cervical cancer with 2018FIGO stage correction：a multicenter Retrospective Cohort Study

   This article has 11 authors:

   1. Shaojun Chen
   2. Li Hua
   3. Lulu Chen
   4. Manyun Liao
   5. Yurong Chen
   6. Guilan Yang
   7. Chengjun Feng
   8. Xindan Wang
   9. Zhan Lin
   10. Dingyuan Zeng
   11. Qiuling Shi